MARKET RADAR
SENSEX     NIFTY      Refresh
YOU ARE HERE >  Moneycontrol >  Markets > Announcements >  Pharmaceuticals > Announcement - Ajanta Pharma
Ajanta Pharma
BSE: 532331NSE: AJANTPHARMISIN: INE031B01031

3rd-Sep-2012 14:18Source: NSE

Ajanta Pharma Limited

Ravi Purushottam Agrawal has submitted to the Exchange vide its letter dated August 31, 2012 a copy of disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011.

More Announcements on:

22nd-May-2013 13:38Source: BSE

Ajanta Pharma - Re: Date of Annual General Meeting (AGM on July 26, 2013)

21st-May-2013 17:55Source: NSE

Ajanta Pharma Limited

21st-May-2013 15:36Source: BSE

Ajanta Pharma - Fixes Book Closure for Dividend & AGM

21st-May-2013 15:26Source: NSE

Ajanta Pharma Limited

21st-May-2013 15:25Source: BSE

Ajanta Pharma - Change in Directorate

16th-May-2013 12:47Source: NSE

Ajanta Pharma Limited

15th-May-2013 12:52Source: NSE

Ajanta Pharma Limited

13th-May-2013 14:45Source: BSE

Ajanta Pharma - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

11th-May-2013 15:06Source: BSE

Ajanta Pharma - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

10th-May-2013 18:10Source: NSE

Ajanta Pharma Limited

1 2 3 4 5 Next >>
Add to Watchist
close[x]
Have you invested in these stocks? You can track them better in your Portfolio
Edit Watchlist
JSW Steel Q4 net dips 24% as shortages of iron ore forced it to operate below capacity. Does the mining sector in India require a boost?
Yes
No

Follow moneycontrol.com

Facebook Twitter Google Plus RSS Wap SMS SMS Alert iPad iPhone Blackberry OVI Android Window